Cannabis Pharmaceuticals Market Size, Share, Trends, Growth Outlook

Cannabis Pharmaceuticals Market is estimated to increase at a growth rate of 34.5% CAGR over the forecast period from 2024 to 2030.

The Cannabis Pharmaceuticals Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Brand (Sativex, Epidiolex, Others).

An Introduction to Cannabis Pharmaceuticals Market in 2024

The Cannabis Pharmaceuticals market in 2024 represents a burgeoning sector of the pharmaceutical industry focused on developing cannabis-based medications for various medical conditions and symptoms. Cannabis pharmaceuticals include prescription drugs and cannabinoid-based therapies targeting indications such as epilepsy, multiple sclerosis, chemotherapy-induced nausea, and chronic pain. Market dynamics are driven by factors such as increasing clinical research on cannabinoids, regulatory approvals for cannabis-based medications, and patient demand for alternative and complementary therapies. Collaboration between pharmaceutical companies, researchers, healthcare providers, and regulatory agencies drives innovation and market expansion in cannabis pharmaceuticals, offering new treatment options and improved outcomes for patients with unmet medical needs.

Cannabis Pharmaceuticals Market Trend: Increasing Acceptance and Legalization of Medical Cannabis

A prominent trend in the Cannabis Pharmaceuticals market is the increasing acceptance and legalization of medical cannabis. As more countries and regions legalize medical cannabis use, there is a growing acceptance of cannabis-based pharmaceuticals as legitimate treatment options for various medical conditions. This trend is driven by evolving attitudes towards cannabis, coupled with mounting clinical evidence supporting its efficacy in managing chronic pain, epilepsy, multiple sclerosis, and other medical ailments. As a result, pharmaceutical companies are increasingly investing in research and development to harness the therapeutic potential of cannabis-derived compounds.

Cannabis Pharmaceuticals Market Driver: Rising Demand for Alternative Therapeutic Solutions

The primary driver for the Cannabis Pharmaceuticals market is the rising demand for alternative therapeutic solutions. With growing concerns about the opioid epidemic, side effects of traditional pharmaceuticals, and limited treatment options for certain medical conditions, there is a heightened interest in exploring alternative therapies like medical cannabis. Patients and healthcare professionals are increasingly seeking non-opioid, non-addictive, and potentially safer alternatives for pain management, symptom relief, and disease treatment. This demand for alternative therapeutic solutions fuels the development and commercialization of cannabis-based pharmaceuticals by pharmaceutical companies and biotech firms.

Cannabis Pharmaceuticals Market Opportunity: Development of Targeted Cannabinoid-Based Therapies

An opportunity in the Cannabis Pharmaceuticals market lies in the development of targeted cannabinoid-based therapies tailored to specific medical conditions and patient populations. While cannabis contains numerous cannabinoids with diverse therapeutic properties, there is still significant untapped potential for identifying and isolating cannabinoids that target specific disease pathways and symptoms. Pharmaceutical companies can leverage advanced research techniques and drug discovery platforms to identify novel cannabinoid compounds, optimize their pharmacological profiles, and develop precision medicines for indications such as neuropathic pain, chemotherapy-induced nausea and vomiting, and inflammatory disorders. By focusing on targeted cannabinoid-based therapies, companies can address unmet medical needs, differentiate their product offerings, and capture market share in the rapidly evolving Cannabis Pharmaceuticals landscape.

Cannabis Pharmaceuticals Market Segmentation

By Brand
Sativex
Epidiolex
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Cannabis Pharmaceuticals Market Companies

AbbVie Inc
Bausch Health Companies Inc
Insys Therapeutics Inc
Jazz Pharmaceuticals Inc

 

 

Reasons to Buy the Cannabis Pharmaceuticals Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cannabis Pharmaceuticals Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cannabis Pharmaceuticals Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Cannabis Pharmaceuticals Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Cannabis Pharmaceuticals Market Size Outlook, $ Million, 2021 to 2030
3.2 Cannabis Pharmaceuticals Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cannabis Pharmaceuticals Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cannabis Pharmaceuticals Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cannabis Pharmaceuticals Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Cannabis Pharmaceuticals Market Industry
4.2 Key Market Trends in Cannabis Pharmaceuticals Market Industry
4.3 Potential Opportunities in Cannabis Pharmaceuticals Market Industry
4.4 Key Challenges in Cannabis Pharmaceuticals Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Cannabis Pharmaceuticals Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Cannabis Pharmaceuticals Market Outlook By Segments
7.1 Cannabis Pharmaceuticals Market Outlook by Segments
By Brand
Sativex
Epidiolex
Others

8 North America Cannabis Pharmaceuticals Market Analysis And Outlook To 2030
8.1 Introduction to North America Cannabis Pharmaceuticals Markets in 2024
8.2 North America Cannabis Pharmaceuticals Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cannabis Pharmaceuticals Market size Outlook by Segments, 2021-2030
By Brand
Sativex
Epidiolex
Others

9 Europe Cannabis Pharmaceuticals Market Analysis And Outlook To 2030
9.1 Introduction to Europe Cannabis Pharmaceuticals Markets in 2024
9.2 Europe Cannabis Pharmaceuticals Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cannabis Pharmaceuticals Market Size Outlook By Segments, 2021-2030
By Brand
Sativex
Epidiolex
Others

10 Asia Pacific Cannabis Pharmaceuticals Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Cannabis Pharmaceuticals Markets in 2024
10.2 Asia Pacific Cannabis Pharmaceuticals Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cannabis Pharmaceuticals Market size Outlook by Segments, 2021-2030
By Brand
Sativex
Epidiolex
Others

11 South America Cannabis Pharmaceuticals Market Analysis And Outlook To 2030
11.1 Introduction to South America Cannabis Pharmaceuticals Markets in 2024
11.2 South America Cannabis Pharmaceuticals Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cannabis Pharmaceuticals Market size Outlook by Segments, 2021-2030
By Brand
Sativex
Epidiolex
Others

12 Middle East And Africa Cannabis Pharmaceuticals Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Cannabis Pharmaceuticals Markets in 2024
12.2 Middle East and Africa Cannabis Pharmaceuticals Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cannabis Pharmaceuticals Market size Outlook by Segments, 2021-2030
By Brand
Sativex
Epidiolex
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AbbVie Inc
Bausch Health Companies Inc
Insys Therapeutics Inc
Jazz Pharmaceuticals Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Brand
Sativex
Epidiolex
Others